Zenith Capital Overview

  • Founded
  • 2013
Founded
  • Status
  • Public
  • Employees
  • 16
Employees
  • Stock Symbol
  • ZENI.P
Stock Symbol
  • Share Price
  • $0.11
  • (As of Tuesday Closing)

Zenith Capital General Information

Description

Zenith Capital Corp is a clinical stage biotechnology company. It develops bromodomain and extraterminal domain protein (BET) inhibitors for the treatment of cancer and other disorders with unmet medical need. Its pipeline product ZEN-3694, will help for the treatment of metastatic castration resistant prostate cancer.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Stock Exchange
TSX
Primary Office
  • 4820 Richard Road South West
  • Suite 300
  • Calgary, Alberta T3E 6L1
  • Canada
+1 (587) 000-0000

Zenith Capital Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Zenith Capital Stock Performance

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.11 $0.11 $0.10 - $0.26 $15.2M 135M 9.2K -$0.06

Zenith Capital Financials Summary

In Thousands,
USD
TTM 30-Apr-2021 FY 2021 30-Apr-2021 FY 2020 30-Apr-2020 FY 2019 30-Apr-2019
EV 28,219 28,219
Revenue 0 0 0 0
EBITDA (6,676) (6,676) (9,251) (11,028)
Net Income (6,913) (6,913) (9,630) (11,327)
Total Assets 3,329 3,329 3,405 3,919
Total Debt 2,654 2,654 589 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Zenith Capital Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Zenith Capital‘s full profile, request access.

Request a free trial

Zenith Capital Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Zenith Capital Corp is a clinical stage biotechnology company. It develops bromodomain and extraterminal domain protein
Biotechnology
Calgary, Canada
16 As of 2021
000.00
000000000 000.00

0000000

olore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliqu
0000 000000000
Fort Worth, TX
0 As of 0000
000.00
00.00 0000-00-00
00000000000 000.00

00000000

irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Except
0000000000000
San Diego, CA
000 As of 0000
00000
000000000 - 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Zenith Capital Competitors (90)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Actuate Therapeutics Venture Capital-Backed Fort Worth, TX 0 000.00 00000000000 000.00
00000000 000000000 Formerly VC-backed San Diego, CA 000 00000 000000000 - 00000
000000000 Formerly VC-backed Gaithersburg, MD 00 00000 00000000 00000
0000 00000000000 Venture Capital-Backed Cambridge, MA 00 00000 00000000000 00000
000000 Venture Capital-Backed Rochester, MN 00 000.00 00000000000 000.00
You’re viewing 5 of 90 competitors. Get the full list »

Zenith Capital Executive Team (6)

Name Title Board Seat Contact Info
Sanjay Lakhotia Ph.D Executive
Henrik Hansen Ph.D Senior Vice President
Donald McCaffrey Chief Executive Officer & Chairman
Brad Cann Chief Financial Officer
You’re viewing 4 of 6 executive team members. Get the full list »

Zenith Capital Board Members (6)

Name Representing Role Since
Donald McCaffrey Self Chief Executive Officer & Chairman 000 0000
Eldon Smith MD Self Board Member 000 0000
Kelly McNeill Self Board Member 000 0000
Kenneth Zuerblis Self Board Member 000 0000
Norman Wong MD Self Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »

Zenith Capital Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Zenith Capital Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Zenith Capital‘s full profile, request access.

Request a free trial